World Investment Advisors LLC boosted its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 6.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,289 shares of the health services provider’s stock after buying an additional 326 shares during the period. World Investment Advisors LLC’s holdings in Maximus were worth $493,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Inspire Advisors LLC lifted its stake in shares of Maximus by 1.4% in the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock valued at $751,000 after purchasing an additional 121 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in Maximus by 4.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock valued at $272,000 after purchasing an additional 136 shares in the last quarter. Petrus Trust Company LTA raised its position in Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after purchasing an additional 185 shares in the last quarter. WR Wealth Planners LLC raised its position in shares of Maximus by 4.6% in the 2nd quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock worth $388,000 after acquiring an additional 198 shares in the last quarter. Finally, Holocene Advisors LP raised its position in shares of Maximus by 6.5% in the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock worth $366,000 after acquiring an additional 239 shares in the last quarter. 97.21% of the stock is owned by institutional investors.
Insider Buying and Selling at Maximus
In other news, insider Michelle F. Link sold 2,208 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the sale, the insider now owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Raymond B. Ruddy bought 3,490 shares of the stock in a transaction dated Thursday, December 12th. The stock was bought at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 1.40% of the company’s stock.
Maximus Trading Down 1.6 %
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Shareholders of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 1.71%. Maximus’s payout ratio is presently 24.00%.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered Maximus from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.
Get Our Latest Stock Analysis on Maximus
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
- Five stocks we like better than Maximus
- Trading Stocks: RSI and Why it’s Useful
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- How to buy stock: A step-by-step guide for beginners
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- The 3 Best Fintech Stocks to Buy Now
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.